(Q35108342)

6 August 2017

title

Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma (English)

1 reference

von Hippel-Lindau disease

6 August 2017

0 references

1 reference

R S Bhatt

1

1 reference

6 August 2017

A J Zurita

2

1 reference

6 August 2017

A O'Neill

3

1 reference

6 August 2017

A Norden-Zfoni

4

1 reference

6 August 2017

L Zhang

5

1 reference

6 August 2017

H K Wu

6

1 reference

6 August 2017

P Y Wen

7

1 reference

6 August 2017

D George

8

1 reference

6 August 2017

V P Sukhatme

9

1 reference

6 August 2017

M B Atkins

10

1 reference

6 August 2017

J V Heymach

11

1 reference

6 August 2017

language of work or name

English

0 references

publication date

14 June 2011

1 reference

British Journal of Cancer

6 August 2017

published in

1 reference

6 August 2017

volume

105

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

112-117

1 reference

Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Biomarkers for monitoring antiangiogenic therapy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

The genetic basis of cancer of the kidney

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Isolation of putative progenitor endothelial cells for angiogenesis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

9 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.186

Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.186

Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.186

Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.186

Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137404

Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects

27 September 2018

1 reference

12 December 2020

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis

1 reference

12 December 2020

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

1 reference

12 December 2020

Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2011.186

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference

6 August 2017

1 reference